Indications
Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Irinotecan
Liposarcoma
Milton S. Hershey Medical Center
P1/2
CC
(47)
irl757
Parkinson Disease
Integrative Research Laboratories AB
P1/2
CC
(47)
Isatuximab
Hematopoietic And Lymphoid System Neoplasm
Indapta Therapeutics, INC.
P1/2
CC
(47)
ism3412
Metastatic Neoplasm
InSilico Medicine Hong Kong Limited
P1/2
CC
(47)
Ivuxolimab
Metastatic Prostate Carcinoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
Ivuxolimab
Prostate Cancer
M.D. Anderson Cancer Center
P1/2
CC
(47)
Jab-2485
Estrogen-Receptor Positive Breast Cancer
Jacobio Pharmaceuticals Co., Ltd.
P1/2
CC
(47)
Jab-8263
Esophageal Squamous Cell Carcinoma
Jacobio Pharmaceuticals Co., Ltd.
P1/2
CC
(47)
jk08
Papillary Renal Cell Carcinoma
Salubris Biotherapeutics Inc
P1/2
CC
(47)
Jnj-54135419
Chronic Rhinosinusitis
The Second People's Hospital of Huai'an
P1/2
CC
(47)
js212 for
Cancer
Shanghai Junshi Bioscience Co., Ltd.
P1/2
CC
(47)
Kat-101
Fibrolamellar Hepatocellular Carcinoma
Primocure Pharma
P1/2
CC
(47)
Kat-201
Fibrolamellar Hepatocellular Carcinoma
Primocure Pharma
P1/2
CC
(47)
kb707
Non-Small Cell Lung Carcinoma
Krystal Biotech, Inc.
P1/2
CC
(47)
kb707
Melanoma
Krystal Biotech, Inc.
P1/2
CC
(47)
Lacutoclax
Follicular Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P1/2
CC
(47)
Lenalidomide
Aggressive B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(47)
Lenalidomide
Corneal Disorder
Hellenic Society of Hematology
P1/2
CC
(47)
Lenalidomide
Monoclonal Gammopathy
Hellenic Society of Hematology
P1/2
CC
(47)
Lenalidomide
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P1/2
CC
(47)
Lentivirus Vector Ccr5 Shrna
HIV Infectious Disease
AIDS Malignancy Consortium
P1/2
CC
(47)
Lenvatinib
Papillary Renal Cell Carcinoma
Salubris Biotherapeutics Inc
P1/2
CC
(47)
Levofolinic Acid
Esophageal Cancer
Merck Sharp & Dohme LLC
P1/2
CC
(47)
Linperlisib
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Peking Union Medical College Hospital
P1/2
CC
(47)
Lisaftoclax
Amyloidosis
Ascentage Pharma Group Inc.
P1/2
CC
(47)
Showing 2451 to 2475 of 6,308 assets
Previous
Page 99 of 253
Next